AAPL 172.1 1.6539% MSFT 395.31 0.0937% GOOG 166.48 0.5496% GOOGL 164.73 0.5309% AMZN 182.38 1.8883% NVDA 846.16 1.8967% META 439.67 0.1093% TSLA 179.3699 -0.3445% TSM 135.09 0.1112% LLY 758.546 -2.3436% V 268.215 0.3348% AVGO 1229.805 -1.0504% JPM 190.26 -0.8339% UNH 491.02 1.4274% NVO 125.38 -2.9642% WMT 59.575 1.2319% LVMUY 164.4 0.2317% XOM 116.2472 0.1872% LVMHF 826.0 0.4463% MA 442.48 0.0927%
Last update at 2024-05-02T15:12:00Z
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Income before tax | 550.99M | -252.51400M | 401.22M | 9.09M | -60.83000M |
| Minority interest | -0.85600M | 0.39M | -20.34600M | -66.63000M | -57.69300M |
| Net income | 533.41M | -265.55500M | 348.59M | -6.58600M | -81.94900M |
| Selling general administrative | 379.49M | 395.08M | 293.60M | 219.97M | 181.02M |
| Selling and marketing expenses | 1768.67M | 1981.28M | 1222.01M | 722.72M | 454.84M |
| Gross profit | 5701.33M | 4107.99M | 3617.25M | 2231.38M | 1331.26M |
| Reconciled depreciation | 63.72M | 60.58M | 39.63M | 41.69M | 3.99M |
| Ebit | 493.11M | -792.29500M | 266.18M | -32.52500M | -62.95500M |
| Ebitda | 556.83M | -731.71900M | 305.81M | 9.16M | -58.96600M |
| Depreciation and amortization | 63.72M | 60.58M | 39.63M | 41.69M | 3.99M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 493.11M | -792.29500M | 266.18M | -32.52500M | -62.95500M |
| Other operating expenses | 26794.80M | 21596.46M | 15407.64M | 9638.63M | 5189.20M |
| Interest expense | 5.83M | 3.81M | 2.45M | 21.96M | 27.97M |
| Tax provision | 16.73M | 13.43M | 58.54M | 24.79M | 30.93M |
| Interest income | 331.59M | 209.84M | 165.41M | 56.21M | 25.06M |
| Net interest income | -5.83300M | 206.02M | 162.97M | 34.25M | -2.91000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 16.73M | 13.43M | 58.54M | 24.79M | 30.93M |
| Total revenue | 26763.02M | 20577.62M | 15518.47M | 9596.48M | 5095.87M |
| Total operating expenses | 5733.12M | 5126.84M | 3506.42M | 2273.53M | 1424.60M |
| Cost of revenue | 21061.68M | 16469.62M | 11901.22M | 7365.10M | 3764.60M |
| Total other income expense net | 57.89M | 539.78M | 135.04M | 41.62M | 2.12M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 534.26M | -265.94100M | 342.68M | -15.69600M | -91.76400M |
| Net income applicable to common shares | - | -265.55500M | 348.59M | -6.58600M | -81.94900M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Total assets | 20747.56M | 19201.97M | 17739.20M | 7869.97M | 5981.89M |
| Intangible assets | 309.01M | 326.21M | 2.94M | 4.47M | - |
| Earning assets | - | - | - | - | - |
| Other current assets | - | 63.12M | 11.02M | 60.24M | 1.72M |
| Total liab | 5600.22M | 5129.74M | 3457.60M | 2667.46M | 3245.06M |
| Total stockholder equity | 15173.71M | 14098.42M | 14301.95M | 5269.15M | 2794.52M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 1685.96M | 1242.88M | 828.99M | 712.35M | 630.73M |
| Common stock | 119.13M | 119.10M | 118.86M | 106.11M | 102.90M |
| Capital stock | 119.13M | 119.10M | 118.86M | 106.11M | 102.90M |
| Retained earnings | -841.69100M | -1309.01300M | -985.65200M | -1297.06600M | -1280.59500M |
| Other liab | - | 222.85M | 39.32M | 19.83M | 11.68M |
| Good will | 810.85M | 810.85M | 54.58M | 54.58M | 27.01M |
| Other assets | - | 37.68M | 17.53M | 28.62M | 89.20M |
| Cash | 10917.17M | 10547.85M | 11636.77M | 2594.98M | 280.37M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 5437.44M | 4822.13M | 3400.87M | 2609.90M | 3233.38M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | -10839.37300M | -10412.43700M | -11599.02900M | -2525.22600M | 1419.63M |
| Short term debt | 37.44M | 50.66M | 20.33M | 32.03M | 1700.00M |
| Short long term debt | - | - | - | 0.00000M | 1700.00M |
| Short long term debt total | 77.80M | 135.41M | 37.74M | 69.75M | 1700.00M |
| Other stockholder equity | 15896.26M | 13979.32M | 14183.09M | 5163.04M | 2691.62M |
| Property plant equipment | - | 165.11M | 52.29M | 82.93M | 8.89M |
| Total current assets | 14913.79M | 13565.51M | 14199.73M | 5013.00M | 3303.39M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | 12961.35M | 14244.44M | 5210.10M | 2767.51M |
| Short term investments | - | - | - | 402.49M | 1736.71M |
| Net receivables | 578.08M | 1073.94M | 772.91M | 589.17M | 538.80M |
| Long term debt | - | - | - | - | - |
| Inventory | 2102.31M | 1550.15M | 1468.61M | 1217.26M | 595.79M |
| Accounts payable | 3714.05M | 3528.60M | 2551.55M | 1865.53M | 902.65M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | - | - | - | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 4611.52M | 4316.89M | 3429.68M | 434.82M | 1776.09M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 5833.77M | 5636.46M | 3539.48M | 2856.98M | 2678.49M |
| Capital lease obligations | 77.80M | 135.41M | 37.74M | 69.75M | - |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Investments | -532.43600M | 2799.35M | -4724.61400M | 1359.44M | -2383.12200M |
| Change to liabilities | 0.00000M | 1029.67M | 735.04M | 979.86M | 619.44M |
| Total cashflows from investing activities | - | 1872.31M | -4961.48400M | 1345.38M | -2395.71100M |
| Net borrowings | - | -47.01200M | -31.61600M | -1729.77300M | 1700.00M |
| Total cash from financing activities | -111.27800M | -58.62800M | 8922.41M | 328.81M | 1708.49M |
| Change to operating activities | - | -44.39200M | -122.06500M | -152.54400M | 66.00M |
| Net income | 550.99M | -252.51400M | 401.22M | 9.09M | -60.83000M |
| Change in cash | -104.57700M | 2089.15M | 4657.29M | 2314.61M | -228.04800M |
| Begin period cash flow | 9341.43M | 7252.27M | 2594.98M | 280.37M | 508.42M |
| End period cash flow | 9236.85M | 9341.43M | 7252.27M | 2594.98M | 280.37M |
| Total cash from operating activities | 255.69M | 424.36M | 1009.43M | 583.62M | 396.37M |
| Issuance of capital stock | 12.89M | 9.69M | 8993.71M | 2112.56M | 52.98M |
| Depreciation | 63.72M | 60.58M | 39.63M | 41.69M | 3.99M |
| Other cashflows from investing activities | - | -112.08600M | -234.52800M | 5.55M | -3.65900M |
| Dividends paid | - | - | - | - | 2293.54M |
| Change to inventory | -711.69400M | -129.20000M | -283.82600M | -638.96000M | -141.47300M |
| Change to account receivables | -64.62600M | -201.98300M | 7.44M | 41.80M | -275.29900M |
| Sale purchase of stock | -81.58200M | -16.51900M | -39.58000M | -17.81400M | -37.84600M |
| Other cashflows from financing activities | -42.58600M | -51.80200M | -31.72600M | -65.93400M | 2297.52M |
| Change to netincome | - | -24.75600M | 284.62M | 318.36M | 205.66M |
| Capital expenditures | 5.92M | 15.12M | 17.56M | 13.51M | 6.10M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -568.13000M | 671.12M | 294.65M | 233.94M | 268.01M |
| Stock based compensation | 308.89M | 408.10M | 396.96M | 277.14M | 213.49M |
| Other non cash items | -99.78300M | -462.92200M | -123.02500M | 21.75M | -28.28800M |
| Free cash flow | 249.77M | 409.25M | 991.87M | 570.10M | 390.27M |
Sector: Healthcare Industry: Pharmaceutical Retailers
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ALBHF Alibaba Health Information Technology Limited |
0.06 15.49% | 0.41 | 48.00 | 62.11 | 0.25 | 3.04 | 0.20 | 6.01 |
| WBA Walgreens Boots Alliance Inc |
- -% | 17.34 | - | 7.60 | 0.16 | 1.09 | 0.39 | -21.1795 |
| RADLY Raia Drogasil SA ADR |
- -% | 5.00 | 47.15 | 32.68 | 0.34 | 9.83 | 0.35 | 3.29 |
| ALBBY Alibaba Health Information Technology Limited |
- -% | 6.89 | 63.53 | 135.14 | 0.27 | 3.41 | 0.19 | 5.91 |
| SHPPF Shop Apotheke Europe N.V |
- -% | 148.00 | - | - | 2.80 | 2.28 | 1.70 | 78.78 |
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, adult and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and traditional Chinese medicine through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, AMap, Freshippo, DingTalk, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
Tower One, Causeway Bay, Hong Kong
| Name | Title | Year Born |
|---|---|---|
| Mr. Shunyan Zhu | Chairman & CEO | 1971 |
| Mr. Yanwu Tu | CFO & Exec. Director | 1979 |
| Mr. Difan Shen | COO & Exec. Director | 1979 |
| Mr. Chun Chung Kwong | Financial Controller | NA |
| Ms. Chun Ka Yan | Company Sec. | NA |
| Ka Yan Chun | Company Sec. | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
US 
AU
UK
CA
NZ
Please wait processing your request...